<DOC>
	<DOCNO>NCT01779193</DOCNO>
	<brief_summary>B streptococcal infection major cause death baby bear . B streptococcus infection way newborn , usually infection mother childbirth , pregnant woman pregnancy early diagnosis B streptococcus infection , effective preventing risk neonatal infection . Department Health China since April 15 , 2012 , Scholarship holder pregnant woman 35-37 week pregnancy comprehensive B streptococcus screening . Infection B Streptococcus pregnant woman labor process , use prophylactic antibiotic effective reduce neonatal B streptococcus infection , possibility fetus infect condition premature birth early rupture membrane still unable fully hedge . In study , 35 37 week gestation examination confirm infected B Streptococcus pregnant woman , oral lactobacillus capsule B streptococcus infection treatment efficacy safety assessment clinical research . To assess whether oral administration lactic acid bacteria affect vaginitis incidence .</brief_summary>
	<brief_title>Probiotics Capsule Supplemental Therapy Group B Streptococci Infection Vaginitis During Pregnancy</brief_title>
	<detailed_description>Deeply influence bacterial vaginosis infection pregnancy pregnant woman fetus childbirth , Group B Streptococcus agalactiae ( GBS ) generally 30 % pregnant woman infect , 1 % vertical infect fetus , baby infect 50 % mortality rate treatment status , consider important reason infection death baby bear . Vertically natural childbirth process infect fetus , delay treatment fetus often lead serious complication , include sepsis , pneumonia meningitis , serious cause death permanent neurological sequela , give confirm diagnosis antibiotic treatment pregnant woman , probability infection newborn B streptococcus reduce 75 % . U.S. Centers Disease Control recommend pregnant woman 35 37 week gestation le 37 week preterm contraction rupture membrane . B streptococcus check preterm doubt pregnant woman labor process use preventive antibiotic effective reduce neonatal B streptococcus infection , condition premature birth early rupture membrane fully prevent possibility fetus infect still pre-production make disposal , cause infection B The streptococci pregnant woman worry , great pressure . This study 35 37 week gestation check confirm infection B Streptococcus pregnant woman , pregnant woman infect clinical study treatment efficacy safety assessment B streptococcus delivery oral administration lactic acid bacteria . The trial expect execution June 2012 July 2015 , subject number expect include least 120 pregnant woman choose subject accord conventional injection prophylactic antibiotic labor process , choose take oral lactobacillus oral lactobacillus pregnant woman accordance 1:1 double-blind randomize three group , one following : test group A : oral lactobacillus capsule ( dose 2 x 109 cfu / capsule ) , experimental group B : oral without functional lactobacillus capsule control group : oral administration contain active ingredient ( lactic acid bacteria cranberry ) capsule oral administration lactic acid bacteria delivery process , collect sample vaginal anal secretion , whether positive addition screen B streptococcus , selective medium coat plate culture vaginal odor , itch number pathogen B Streptococcus quantitative analysis assessment questionnaire .</detailed_description>
	<mesh_term>Vaginitis</mesh_term>
	<mesh_term>Streptococcal Infections</mesh_term>
	<criteria>pregnancy woman 35 week gestation previous probiotic capsule use previous antibiotic use previous habitual vaginal douche previous medical disease , : HIV infection , cancer , history organ transplantation , longterm steroid use , autoimmune disease , et al</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>group B streptococcus</keyword>
	<keyword>pregnancy</keyword>
	<keyword>probiotic</keyword>
</DOC>